Renowned medical devices maker CR Bard (BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...
MURRAY HILL, N.J.--(BUSINESS WIRE)-- C. R. Bard, Inc. (NYS: BCR) today announced that it has entered into a definitive agreement to acquire privately-held Neomend, Inc., a leading developer and ...
C. R. Bard has announced it will acquire Neomend, according to a news release. Bard will acquire the Neomend for a purchase price of $140 million paid at closing and future contingent payments up to ...
C.R. Bard ($BCR) has agreed to pay $140 million up-front for Neomend, a California maker of products to seal air leaks in the lungs after surgery. The deal is ...
C. R. Bard announced that it has entered into a definitive agreement to acquire privately-held Neomend, a leading developer and supplier of sprayable surgical sealants and anti-adhesion products for a ...
Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced it has received the European Union CE Mark for the company's ProGEL® PLATINUM Surgical ...
IRVINE, Calif., June 17 NeoMend, Inc. today announced thatits ProGEL(TM) Surgical Sealant has received a recommendation for approvalfrom the U.S. Food and Drug Administration's (FDA) Anesthesiology ...
Renowned medical devices maker CR Bard (BCR) recently announced a definitive agreement to purchase leading thoracic sealing company Neomend Inc. for $140 million in cash and will pay contingent ...
Neomend markets the Progel ® Air Leak Sealant, which is the only FDA-approved product available for intraoperative sealing of air leaks following lung resection and has a CE mark for lung sealing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback